Faculty, Staff and Student Publications

Language

English

Publication Date

4-1-2025

Journal

Nature Cancer

DOI

10.1038/s43018-025-00935-0

PMID

40181089

PMCID

PMC13470645

PubMedCentral® Posted Date

8-14-2026

PubMedCentral® Full Text Version

Author MSS

Abstract

Host effector CD4+ T cells emerge as critical mediators for tumor regression but whether they can be activated by adoptively transferred CD8+ T cells remains unknown. We previously reported that adoptive transfer of interleukin 9 (IL-9)-producing cytotoxic CD8+ T (Tc9) cells achieved long-term control of tumor growth. Here, we demonstrate that murine tumor-specific Tc9 cells control the outgrowth of antigen-loss relapsed tumors by recruiting and activating host effector CD4+ T cells. Tc9 cells secreted IL-24 and recruited CCR7-expressing conventional type 2 dendritic cells (cDC2 cells) into tumor-draining lymph nodes to prime host CD4+ T cells against relapsed tumors. Host CD4+ T cell or cDC2 deficiency impaired the ability of Tc9 cells to control relapsed tumor outgrowth. Additionally, intratumoral IL24 expression correlates with cDC2 and CD4+ T cell gene signatures in human cancers and their expression is associated with better patient survival. This study reports a mechanism for activation of tumor-specific CD4+ T cells in vivo.

Keywords

Animals, CD4-Positive T-Lymphocytes, Mice, CD8-Positive T-Lymphocytes, Interleukins, Humans, Lymphocyte Activation, Adoptive Transfer, Dendritic Cells, Mice, Inbred C57BL, T-Lymphocytes, Cytotoxic, Antigens, Neoplasm, Immunotherapy, Adoptive, Cell Line, Tumor, Neoplasms, Interleukin-24

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.